This protocol is judged by an institutional review board, an impartial team that critiques any clinical trials involving people. If a review includes a Schedule I drug, after the board approves the protocol as moral, the researchers should apply for an investigational new drug (IND) selection from your FDA.And Considering that the copyright is goin